Joshua Silverman - Net Worth and Insider Trading

Joshua Silverman Net Worth

The estimated net worth of Joshua Silverman is at least $165,592 dollars as of 2024-05-17. Joshua Silverman is the Director of Neurotrope Inc and owns about 100,000 shares of Neurotrope Inc (NTRP) stock worth over $94,100. Joshua Silverman is the Director of AYRO Inc and owns about 49,437 shares of AYRO Inc (AYRO) stock worth over $56,358. Joshua Silverman is also the Director of Synaptogenix Inc and owns about 1,530 shares of Synaptogenix Inc (SNPX) stock worth over $7,268. Besides these, Joshua Silverman also holds MyMD Pharmaceuticals Inc (MYMD) , DropCar Inc (DCAR) . Details can be seen in Joshua Silverman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua Silverman has not made any transactions after 2023-08-01 and currently still holds the listed stock(s).

Transaction Summary of Joshua Silverman

Joshua Silverman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua Silverman owns 13 companies in total, including Neurotrope Inc (NTRP) , AYRO Inc (AYRO) , and Akers Biosciences Inc (AKER) among others .

Click here to see the complete history of Joshua Silverman’s form 4 insider trades.

Insider Ownership Summary of Joshua Silverman

Ticker	Comapny	Transaction Date	Type of Owner
NTRP	Neurotrope Inc	2020-10-16	director
AYRO	AYRO Inc	2023-08-01	director
AKER	Akers Biosciences Inc	2020-09-11	director
		2016-02-12	director
		2017-08-29	director
		2016-09-12	director
		2014-09-29	10 percent owner
		2016-02-25	director
		2011-06-22	10 percent owner
		2021-11-26	director
		2022-12-16	director
		2020-12-01	director
		2022-08-15	director

Joshua Silverman Latest Holdings Summary

Joshua Silverman currently owns a total of 5 stocks. Among these stocks, Joshua Silverman owns 100,000 shares of Neurotrope Inc (NTRP) as of October 16, 2020, with a value of $94,100 and a weighting of 56.83%. Joshua Silverman owns 49,437 shares of AYRO Inc (AYRO) as of August 1, 2023, with a value of $56,358 and a weighting of 34.03%. Joshua Silverman also owns 1,530 shares of Synaptogenix Inc (SNPX) as of December 16, 2022, with a value of $7,268 and a weighting of 4.39%. The other 2 stocks MyMD Pharmaceuticals Inc (MYMD) , DropCar Inc (DCAR) have a combined weighting of 4.75% among all his current holdings.

Latest Holdings of Joshua Silverman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NTRP	Neurotrope Inc	2020-10-16	100,000	0.94	94,100
AYRO	AYRO Inc	2023-08-01	49,437	1.14	56,358
SNPX	Synaptogenix Inc	2022-12-16	1,530	4.75	7,268
MYMD	MyMD Pharmaceuticals Inc	2021-11-26	2,959	2.35	6,954
DCAR	DropCar Inc	2018-06-26	1,170	0.78	913

Holding Weightings of Joshua Silverman

Joshua Silverman Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua Silverman has made a total of 2 transactions in Neurotrope Inc (NTRP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Neurotrope Inc is the acquisition of 50,000 shares on October 16, 2020, which cost Joshua Silverman around $54,500.

According to the SEC Form 4 filings, Joshua Silverman has made a total of 5 transactions in AYRO Inc (AYRO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AYRO Inc is the sale of 1,592 shares on August 1, 2023, which brought Joshua Silverman around $10,447.

According to the SEC Form 4 filings, Joshua Silverman has made a total of 1 transactions in Synaptogenix Inc (SNPX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Synaptogenix Inc is the sale of 760 shares on December 16, 2022, which brought Joshua Silverman around $22,244.

More details on Joshua Silverman's insider transactions can be found in the Insider Trading History of Joshua Silverman table.

Insider Trading History of Joshua Silverman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua Silverman Trading Performance

GuruFocus tracks the stock performance after each of Joshua Silverman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Silverman is -53.85%. GuruFocus also compares Joshua Silverman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Silverman within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua Silverman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua Silverman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-10.22
Relative Return to S&P 500(%)	-13.74

Joshua Silverman Ownership Network

Ownership Network List of Joshua Silverman

No Data

Ownership Network Relation of Joshua Silverman

Joshua Silverman Owned Company Details

What does Neurotrope Inc do?

Who are the key executives at Neurotrope Inc?

Joshua Silverman is the director of Neurotrope Inc. Other key executives at Neurotrope Inc include director & Chief Executive Officer Charles S. Ryan , COO and General Counsel Michael Ciraolo , and See Remarks Robert Weinstein .

Neurotrope Inc (NTRP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurotrope Inc Insider Transactions

No Available Data

What does AYRO Inc do?

Who are the key executives at AYRO Inc?

Joshua Silverman is the director of AYRO Inc. Other key executives at AYRO Inc include Chief Executive Officer Thomas Michael Wittenschlaeger , Interim CFO David E. Hollingsworth , and director & Chief Executive Officer Keller Rodney C. Jr. .

AYRO Inc (AYRO) Insider Trades Summary

Over the past 18 months, Joshua Silverman made 3 insider transaction in AYRO Inc (AYRO) with a net sale of 31,838. Other recent insider transactions involving AYRO Inc (AYRO) include a net sale of 32,718 shares made by Zvi Joseph , a net sale of 18,178 shares made by Wayne Remell Walker , and a net sale of 18,178 shares made by George Devlin .

In summary, during the past 3 months, insiders sold 0 shares of AYRO Inc (AYRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,159 shares of AYRO Inc (AYRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,159 shares.

AYRO Inc (AYRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AYRO Inc Insider Transactions

No Available Data

What does Akers Biosciences Inc do?

Who are the key executives at Akers Biosciences Inc?

Joshua Silverman is the director of Akers Biosciences Inc. Other key executives at Akers Biosciences Inc include director & Exec. Chairman and President Christopher C Schreiber , Chief Financial Officer Stuart M Benson , and 10 percent owner Hudson Bay Capital Management Lp .

Akers Biosciences Inc (AKER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akers Biosciences Inc (AKER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akers Biosciences Inc (AKER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akers Biosciences Inc (AKER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akers Biosciences Inc Insider Transactions

No Available Data

What does Protagenic Therapeutics Inc do?

Who are the key executives at Protagenic Therapeutics Inc?

Joshua Silverman is the director of Protagenic Therapeutics Inc. Other key executives at Protagenic Therapeutics Inc include Chief Financial Officer Alexander K. Arrow , director & 10 percent owner & See Remarks Garo H Armen , and COO / Interim President Robert Ziroyan .

Protagenic Therapeutics Inc (PTIX) Insider Trades Summary

Over the past 18 months, Joshua Silverman made no insider transaction in Protagenic Therapeutics Inc (PTIX). Other recent insider transactions involving Protagenic Therapeutics Inc (PTIX) include a net purchase of 8,000 shares made by Alexander K. Arrow ,

In summary, during the past 3 months, insiders sold 0 shares of Protagenic Therapeutics Inc (PTIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protagenic Therapeutics Inc (PTIX) were sold and 8,000 shares were bought by its insiders, resulting in a net purchase of 8,000 shares.

Protagenic Therapeutics Inc (PTIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protagenic Therapeutics Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Joshua Silverman is the director of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does National Holdings Corp do?

Who are the key executives at National Holdings Corp?

Joshua Silverman is the director of National Holdings Corp. Other key executives at National Holdings Corp include 10 percent owner Daniel Asher , President and CFO Glenn C. Worman , and Chief Operating Officer John C. Desena .

National Holdings Corp (NHLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of National Holdings Corp (NHLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of National Holdings Corp (NHLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

National Holdings Corp (NHLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

National Holdings Corp Insider Transactions

No Available Data

What does MGT Capital Investments Inc do?

Who are the key executives at MGT Capital Investments Inc?

Joshua Silverman is the 10 percent owner of MGT Capital Investments Inc. Other key executives at MGT Capital Investments Inc include Chief Operating Officer Stephen Schaeffer , director & 10 percent owner Robert Ladd , and CFO & Treasurer & Secretary Robert S Lowrey .

MGT Capital Investments Inc (MGTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MGT Capital Investments Inc (MGTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MGT Capital Investments Inc (MGTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MGT Capital Investments Inc (MGTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

MGT Capital Investments Inc Insider Transactions

No Available Data

What does Alanco Technologies Inc do?

Who are the key executives at Alanco Technologies Inc?

Joshua Silverman is the director of Alanco Technologies Inc. Other key executives at Alanco Technologies Inc include and director & 10 percent owner & CHIEF EXECUTIVE OFFICER Robert R Kauffman .

Alanco Technologies Inc (ALAN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alanco Technologies Inc (ALAN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alanco Technologies Inc (ALAN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alanco Technologies Inc (ALAN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alanco Technologies Inc Insider Transactions

No Available Data

What does XWELL Inc do?

Who are the key executives at XWELL Inc?

Joshua Silverman is the 10 percent owner of XWELL Inc. Other key executives at XWELL Inc include Chief Financial Officer Suzanne A. Scrabis , Chief Executive Officer Scott R Milford , and See Remarks Ezra Ernst .

XWELL Inc (XWEL) Insider Trades Summary

Over the past 18 months, Joshua Silverman made no insider transaction in XWELL Inc (XWEL). Other recent insider transactions involving XWELL Inc (XWEL) include a net purchase of 50,000 shares made by Robert Weinstein , a net purchase of 50,000 shares made by Bruce Bernstein , and a net purchase of 28,750 shares made by Scott R Milford .

In summary, during the past 3 months, insiders sold 0 shares of XWELL Inc (XWEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XWELL Inc (XWEL) were sold and 128,750 shares were bought by its insiders, resulting in a net purchase of 128,750 shares.

XWELL Inc (XWEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

XWELL Inc Insider Transactions

No Available Data

What does MyMD Pharmaceuticals Inc do?

Who are the key executives at MyMD Pharmaceuticals Inc?

Joshua Silverman is the director of MyMD Pharmaceuticals Inc. Other key executives at MyMD Pharmaceuticals Inc include EVP of Operations & GC Paul Rivard , director & President & Chief Med. Officer Chapman Christopher C Jr , and Chief Scientific Officer Adam Kaplin .

MyMD Pharmaceuticals Inc (MYMD) Insider Trades Summary

Over the past 18 months, Joshua Silverman made no insider transaction in MyMD Pharmaceuticals Inc (MYMD). Other recent insider transactions involving MyMD Pharmaceuticals Inc (MYMD) include a net purchase of 185,000 shares made by Paul Rivard ,

In summary, during the past 3 months, insiders sold 0 shares of MyMD Pharmaceuticals Inc (MYMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyMD Pharmaceuticals Inc (MYMD) were sold and 6,167 shares were bought by its insiders, resulting in a net purchase of 6,167 shares.

MyMD Pharmaceuticals Inc (MYMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

MyMD Pharmaceuticals Inc Insider Transactions

No Available Data

What does Synaptogenix Inc do?

Who are the key executives at Synaptogenix Inc?

Joshua Silverman is the director of Synaptogenix Inc. Other key executives at Synaptogenix Inc include Chief Financial Officer Robert Weinstein , director & Chief Scientific Officer Daniel L. Alkon , and director & Chief Executive Officer Alan J Tuchman .

Synaptogenix Inc (SNPX) Insider Trades Summary

Over the past 18 months, Joshua Silverman made 1 insider transaction in Synaptogenix Inc (SNPX) with a net sale of 19,012. Other recent insider transactions involving Synaptogenix Inc (SNPX) include a net sale of 27,000 shares made by Alan J Tuchman , a net sale of 27,000 shares made by Robert Weinstein , and a net sale of 27,000 shares made by William S. Singer .

In summary, during the past 3 months, insiders sold 0 shares of Synaptogenix Inc (SNPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,498 shares of Synaptogenix Inc (SNPX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,498 shares.

Synaptogenix Inc (SNPX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synaptogenix Inc Insider Transactions

No Available Data

What does Petros Pharmaceuticals Inc do?

Who are the key executives at Petros Pharmaceuticals Inc?

Joshua Silverman is the director of Petros Pharmaceuticals Inc. Other key executives at Petros Pharmaceuticals Inc include director & 10 percent owner John D Shulman , 10 percent owner Jcp Iii Sm Aiv, L.p. , and 10 percent owner Juggernaut Partners Iii Gp, L.p. .

Petros Pharmaceuticals Inc (PTPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Petros Pharmaceuticals Inc (PTPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Petros Pharmaceuticals Inc (PTPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Petros Pharmaceuticals Inc (PTPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Petros Pharmaceuticals Inc Insider Transactions

No Available Data

What does PharmaCyte Biotech Inc do?

Who are the key executives at PharmaCyte Biotech Inc?

Joshua Silverman is the director of PharmaCyte Biotech Inc. Other key executives at PharmaCyte Biotech Inc include director & CFO Carlos Trujillo , director & Chairman & CEO & Pres and GC Kenneth L. Waggoner , and director & Chief Science Officer Gerald W Crabtree .

PharmaCyte Biotech Inc (PMCB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PharmaCyte Biotech Inc (PMCB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PharmaCyte Biotech Inc (PMCB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PharmaCyte Biotech Inc (PMCB)'s detailed insider trading history can be found in Insider Trading Tracker table.

PharmaCyte Biotech Inc Insider Transactions

No Available Data

Joshua Silverman Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua Silverman. You might contact Joshua Silverman via mailing address: Iroquois Capital Management Llc, 205 East 42nd St - 20th Fl., New York Ny 10017.

Discussions on Joshua Silverman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.